Information Provided By: 
Fly News Breaks for April 13, 2015
AZN, MRK
Apr 13, 2015 | 08:58 EDT
SunTrust says that FDA briefing documents indicate that AstraZeneca's (AZN) Onglyza showed a heart failure signal in the SAVOR outcome trial. The firm says that the news is positive for Merck's (MRK) Januvia, pending the outcome of a trial of the drug. SunTrust keeps a Buy rating on Merck.
News For MRK;AZN From the Last 2 Days
AZN
Apr 18, 2024 | 09:41 EDT
Unusual total active option classes on open include: Wrap Technologies (WRAP), AstraZeneca (AZN), JetBlue (JBLU), United Continental (UAL), Taiwan Semi (TSM), Nokia (NOK), EBay (EBAY), Maplebear Inc (CART), Airbnb (ABNB), and UnitedHealth (UNH).
